ABVC BIOPHARMA, INC. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by ABVC BIOPHARMA, INC. (ABVC), sorted by most recent first. Each row links to the full filing on EdgarLookup. ABVC BIOPHARMA, INC. has filed 7 DEF 14A documents with the SEC since 2002. To view all SEC filings by ABVC BIOPHARMA, INC., see the full filings list.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
3
3/A
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREM14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-26-024122 | Mar 5, 2026 | Mar 26, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-044910 | May 16, 2025 | Jun 3, 2025 |
| DEF 14A | PROXY STATEMENT | 0001213900-23-100009 | Dec 29, 2023 | Jan 16, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-23-050541 | Jun 21, 2023 | Jul 7, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-23-029671 | Apr 14, 2023 | Apr 24, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-22-021802 | Apr 27, 2022 | May 20, 2022 |
| DEF 14A | DEFINITIVE PROXY 2011 | 0001173313-11-000010 | Jan 20, 2011 | — |